Experimental Studies to Define the Role of Calcium (Ca2+) and Voltage-Gated Calcium Channel Blockers (vCa-CCB) against Neurosteroid Induced Obesity

Simple item page
dc.contributor.authorChidrawar, Vijay R.en_US
dc.contributor.authorAli, Akbaren_US
dc.date.accessioned2020-11-18T10:30:25Z
dc.date.available2020-11-18T10:30:25Z
dc.date.issued2020-05
dc.description.abstractIntroduction:Obesity is closely associated with various types of illness, primarily caused by more calorie intake than body burn. In adipocytes, Calcium (Ca2+) is an important second messenger involved in theregulation of many physiological functions which are essential for survival. In the present research, we have investigated the role of Ca2+ions in obesity by manipulating cytosolic Ca2+ion concentration by selective blocking/advancing the Ca2+ions through the voltage-gated calcium channels. Voltage-gated calcium channel (vCa) plays a key role in regulating intracellular and extracellular Ca2+concentration.Cytoplasmic level of Ca2+was manipulated by supplying calcium carbonateand by using vCa blockers i.e. nifedipine-(N-type-vCa-CCB) and ethosuximide (T-type, vCa-CCB).Methods:Obesity was induced by progesterone in female mice and test drugs were co-administered with progesterone whereas sibutramine was used as standard. The treatment was carried out for 28 days, during and afterthetreatment periodvarious parameters were studied viz food consumption, change in body weight and temperature, the effect on WAT (white adipose tissue, adiposity index, histology of fat pad) and fecal lipid content.Results:Calcium carbonate treated group has shown promising effects in the decrease in body weight by increasing fecal lipid content and lipolysis which was reflected by an increase in body temperature. Ethosuximide also offered significant protection by decreasing the food intake but has not shown any notable effect on fecal fat content, whereas nifedipine has not offered any protection against the obesity induced by neurosteroid.Conclusion:Calcium carbonate has significant anti-obesity activity by including thermogenesis, and increasing fecal lipid contenten_US
dc.identifier.affiliationsDepartment of Pharmacology and Toxicology, Faculty of Pharmacy, Northern Border University,Kingdom of Saudi Arabiaen_US
dc.identifier.affiliationsDepartment of Basic Health Sciences, Faculty of Pharmacy, Northern Border University, Kingdom of Saudi Arabiaen_US
dc.identifier.citationChidrawar Vijay R., Ali Akbar. Experimental Studies to Define the Role of Calcium (Ca2+) and Voltage-Gated Calcium Channel Blockers (vCa-CCB) against Neurosteroid Induced Obesity. Journal of Pharmaceutical Research International. 2020 May; 32(7): 60-71en_US
dc.identifier.issn2456-9119
dc.identifier.issn2231-2919
dc.identifier.placeIndiaen_US
dc.identifier.urihttps://imsear.searo.who.int/handle/123456789/215974
dc.languageenen_US
dc.publisherSCIENCEDOMAIN internationalen_US
dc.relation.issuenumber7en_US
dc.relation.volume32en_US
dc.source.urihttps://doi.org/10.9734/JPRI/2020/v32i730461en_US
dc.subjectObesityen_US
dc.subjectcalcium channelsen_US
dc.subjectcalcium carbonateen_US
dc.subjectethosuximideen_US
dc.subjectfecal lipiden_US
dc.titleExperimental Studies to Define the Role of Calcium (Ca2+) and Voltage-Gated Calcium Channel Blockers (vCa-CCB) against Neurosteroid Induced Obesityen_US
dc.typeJournal Articleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
jpri2020v32n7p60.pdf
Size:
498.17 KB
Format:
Adobe Portable Document Format
Download
Collections
Journal of Pharmaceutical Research International